CIK 0001714899 · Large accelerated filer
Denali Therapeutics Inc.
Sign in to watch- Ticker
- DNLI
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 463872213
- Phone
- (650) 866-8547
- Business address
- 161 OYSTER POINT BLVD., SOUTH SAN FRANCISCO, CA, 94080
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $363,678
- in 3 filings, $327K under 10b5-1 plans
Net −$363,678. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 8 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-09-03 | SATO VICKI L Director | Sale 10b5-1 | −2,980 | $24.99 | $74K | 116,276 |
| 2024-09-03 | SATO VICKI L Director | Sale 10b5-1 | −100 | $25.37 | $3K | 116,176 |
| 2024-08-21 | Schuth Alexander O. COFO and Secretary | Sale 10b5-1 | −2,547 | $24.78 | $63K | 178,066 |
| 2024-08-21 | Ho Carole Chief Medical Officer | Sale 10b5-1 | −14,098 | $24.41 | $344K | 124,717 |
| 2024-08-21 | Ho Carole Chief Medical Officer | Sale 10b5-1 | −5,907 | $24.96 | $147K | 118,810 |
| 2024-08-20 | Watts Ryan J. President and CEO | Sale | −2,260 | $23.79 | $54K | 235,807 |
| 2024-08-20 | Krognes Steve E. Director | Sale | −1,727 | $23.79 | $41K | 32,677 |
| 2024-08-20 | Schuth Alexander O. COFO and Secretary | Sale 10b5-1 | −2,453 | $23.79 | $58K | 183,966 |
| 2024-08-20 | Schuth Alexander O. COFO and Secretary | Sale 10b5-1 | −3,353 | $23.54 | $79K | 180,613 |
| 2024-08-20 | Ho Carole Chief Medical Officer | Sale 10b5-1 | −2,453 | $23.79 | $58K | 138,815 |
| 2024-08-13 | Schuth Alexander O. COFO and Secretary | Sale | −2,272 | $22.89 | $52K | 186,419 |
| 2024-08-13 | Ho Carole Chief Medical Officer | Sale | −2,337 | $22.89 | $53K | 141,268 |
| 2024-07-01 | Krognes Steve E. Director | Sale 10b5-1 | −29,900 | $22.12 | $661K | 34,504 |
| 2024-07-01 | Krognes Steve E. Director | Sale 10b5-1 | −100 | $22.80 | $2K | 34,404 |
| 2024-07-01 | SATO VICKI L Director | Sale 10b5-1 | −2,980 | $22.12 | $66K | 119,356 |
| 2024-07-01 | SATO VICKI L Director | Sale 10b5-1 | −100 | $22.86 | $2K | 119,256 |
| 2024-06-13 | Krognes Steve E. Director | Sale 10b5-1 | −688 | $21.79 | $15K | 52,620 |
| 2024-06-06 | Cook Jennifer E. Director | Sale 10b5-1 | −1,458 | $21.73 | $32K | 20,038 |
| 2024-05-31 | Krognes Steve E. Director | Grant or award | +5,967 | 53,308 | ||
| 2024-05-31 | Krognes Steve E. Director | Grant or award · Stock Option (right to buy) | +17,901 | 17,901 |
Page 6 of 53 · 1,043 trades